OMG Akki im just putting it out there Someone else who is more learned than self is saying what I’m saying..
FDA should never of agreed to the last review swayed by the patent sympathetic plea. FDA was correct : they knew it was not going to show any benefit (efficacy)
Does not compete with Atl1102 @$3 mill Usd Sarepta is not making a profit with the other drugs
Imo : Sarepta will have to get into negotiations with PER
We are all waiting for the Tox results.. For Per to get into the USA .
PER Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
